Differences in methylation profiles between long-term survivors and short-term survivors of IDH- wildtype glioblastoma

Abstract Background Patients with glioblastoma (GBM) have a median overall survival (OS) of approximately 16 months. However, approximately 5% of patients survive >5 years. This study examines the differences in methylation profiles between long-term survivors (>5 years, LTS) a...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Matthijs van der Meulen, Ronald Ramos, Mathew Voisin, Vikas Patil, Qingxia Wei, Olivia Singh, Seth Climans, Navya Kalidindi, Rosemarylin Or, Ken Aldape, Phedias Diamandis, David G. Muñoz, Gelareh Zadeh, Warren Mason
Formáid: Artigo
Teanga:Béarla
Foilsithe / Cruthaithe: 2024
Rochtain ar líne:https://doi.org/10.1093/noajnl/vdae001
https://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae001/55536889/vdae001.pdf
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!